Jerome S. Alexandre
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 147 publications
Prognosis of Recurrent Venous Thromboembolism During Extended Apixaban Therapy for Cancer-Associated Thrombosis: Insights From the API-CAT Randomized Trial.
Journal: Circulation
Published: July 13, 2026
Early Clinical and Molecular Biomarkers in Patients With Advanced Ovarian Cancer Undergoing Neoadjuvant Chemotherapy: CHIVA Phase II GINECO Trial.
Journal: JCO precision oncology
Published: January 14, 2026
Stage I placental site trophoblastic tumor with complete response after pembrolizumab.
Journal: Gynecologic oncology reports
Published: November 16, 2025
French recommendations for clinical practice, Nice/Saint-Paul-de-Vence 2024-2025: Management of advanced/relapsing endometrial cancer
Journal: Bulletin du cancer
Published: October 24, 2025
Therapeutic advances and molecular insights in low-grade serous ovarian carcinoma.
Journal: Bulletin du cancer
Published: October 01, 2025
Baseline value and longitudinal kinetics of circulating nucleosomes during neo-adjuvant chemotherapy in newly diagnosed ovarian cancer: Results from a GINECO/GINEGEPS study of the randomized phase II CHIVA trial.
Journal: Translational oncology
Published: September 29, 2025
Clinical outcome of advanced or recurrent endometrial carcinoma treated with chemotherapy: a French observational retrospective cohort: the ENDOVIE study.
Journal: BMJ open
Published: September 04, 2025
ctDNA for Prognostication and Monitoring in Patients with Metastatic Endometrial Carcinoma Treated with Olaparib: Validation in the GINECO-UTOLA Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 07, 2025
Fasciitis-like primary breast pyoderma gangrenosum: A rare case report
Journal: Annales de chirurgie plastique et esthetique
Published: August 05, 2025
Glutamine metabolism drives tumor aggressiveness but not chemoresistance in ovarian carcinoma cell lines.
Journal: Translational cancer research
Published: August 05, 2025
Association between molecular classification and overall survival in patients with metastatic endometrial carcinoma: ancillary results of the UTOLA phase II GINECO trial.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: August 04, 2025
ESR1 Mutation in Endocrine Treatment-Naïve Endometrial Cancer: Prevalence, Characteristics, and Prognostic Implications, Results from the UTOLA Phase II GINECO Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 24, 2025
Last Updated: 09/26/2026